A detailed history of Pullen Investment Management, LLC transactions in Hcw Biologics Inc. stock. As of the latest transaction made, Pullen Investment Management, LLC holds 75,116 shares of HCWB stock, worth $21,783. This represents 0.03% of its overall portfolio holdings.

Number of Shares
75,116
Previous 85,116 11.75%
Holding current value
$21,783
Previous $55.1 Million 26.42%
% of portfolio
0.03%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$0.42 - $0.7 $4,200 - $7,000
-10,000 Reduced 11.75%
75,116 $40.5 Million
Q1 2024

May 01, 2024

BUY
$1.1 - $1.77 $93,627 - $150,655
85,116 New
85,116 $149 Million

Others Institutions Holding HCWB

About HCW Biologics Inc.


  • Ticker HCWB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,833,100
  • Market Cap $10.4M
  • Description
  • HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...
More about HCWB
Track This Portfolio

Track Pullen Investment Management, LLC Portfolio

Follow Pullen Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pullen Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pullen Investment Management, LLC with notifications on news.